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The synthesis and secretion of plasminogen activator by mouse peritoneal 
macrophages are  correlated with  inflammation: macrophages obtained from 
animals  after intraperitoneal injection  of inflammatory agents  produce the 
enzyme, whereas "resident" macrophages from untreated mice do not (1). Since 
enzyme formation can be both induced  1  and suppressed (2) in vitro, the synthesis 
of macrophage plasminogen activator can be used as a  sensitive and specific 
assay for potential regulatory mediators of the inflammatory response. 
That secretion products of stimulated lymphocytes  can influence macrophage 
biology has been suggested for some time: inhibition of macrophage migration 
(3), macrophage "activation" (4), stimulation of macrophage collagenase produc- 
tion (5), and many other effects have been attributed to such materials. How- 
ever, purification and identification of these lymphocyte products has proven 
difficult, owing perhaps in part to the lack of convenient assays. 
We  show  here  that  conditioned medium from  concanavalin A  (Con  A)  2- 
stimulated mouse spleen cells can both induce the synthesis of plasminogen 
activator by "resident" macrophages obtained from normal, untreated mice, and 
in addition stimulate enzyme production by macrophages "primed" by intraperi- 
toneal injection of thioglycollate medium or endotoxin. Macrophage plasmino- 
gen activator production is a sensitive, quantitative, and rapid assay for further 
study of the inducing factor secreted by lymphocytes. 
Materials and Methods 
Con A  (3 ×  crystallized) was obtained from Miles Laboratories Inc., Miles Research Products, 
Elkhart,  Ind.,  and  a-methyl-D-mannoside  from  Sigma  Chemical  Co.,  St.  Louis,  Mo.  Con  A 
[3H(G)],  50.8 Ci/mmol, was obtained from New England Nuclear, Boston, Mass. The sources of all 
other materials have been given elsewhere (2). All incubations were carried out at 37°C in a  5% 
CO2-95% air atmosphere. 
Preparation of  Conditioned Medium from Cultured Spleen Cells.  Spleens were obtained from 
NCS (The Rockefeller University) mice (25-30 g) and teased apart with forceps  in cold  Dulbecco's 
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2 Abbreviations  used  in  this paper:  Con A,  concanavalin  A; HI  FBS,  heat-inactivated  fetal 
bovine serum;  LCM,  lymphocyte-conditioned medium; NsLCM,  conditioned medium from non- 
stimulated lymphocytes; PBS,  phosphate-buffered saline; sLCM, conditioned medium from Con 
A-stimulated lymphocytes; STI,  soybean trypsin  inhibitor; TD,  0.024  M  Tris  (pH  7.4),  0.14  M 
NaCl, 0.05 M KC1, and 0.0037  M Na2HPO4. 
THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  " VOLUME  145,  1977  429 430  IN  VITRO  INDUCTION  OF  MACROPHAGE  PLASMINOGEN  ACTIVATOR 
medium; tissue clumps were separated by repeated gravity sedimentation (three times for 3 min) 
and discarded; the suspension of single cells was washed in cold Dulbecco's medium, sedimented 
by  centrifugation  (225  g,  10  rain,  4°C),  counted  in  a  hemocytometer  in  Turk's  solution,  and 
resuspended at a density of 6 × 106 nucleated cells/ml in Dulbecco's medium supplemented with 5% 
of fetal bovine serum that had been heat inactivated at 56°C for 30 min (HI FBS). Spleens yielded 
between 5 ×  107 and 1 ×  108 cells, and the cells obtained from 5 to 10 spleens were pooled for each 
experiment.  The cells were cultured for 20 h  in Falcon 100-ram tissue culture Petri dishes (no. 
3003;  Falcon Plastics, Div. of BioQuest, Oxnard, Calif.), at a density of 6  ×  107 cells per plate, in 
presence or absence of 4  p.g/ml Con A. After resuspension by gentle pipetting, the cells from 10 
plates were pooled, centrifuged (225 g, 10 min, 4°C), and washed twice by further resuspension and 
centrifugation in  125  ml  of Dulbecco's medium;  after another hemocytometer count in Turk's 
solution, the cells were again resuspended in Dulbecco's medium at a density of 6  x  t06 cells/ml, 
replated in fresh culture dishes (Falcon no. 3003) at 6 x  107 cells per plate, and incubated at 37°C. 
Lymphocyte-conditioned medium (LCM) was collected 24 h later, centrifuged for 15 min at 500 g to 
remove the cells, and either used immediately or stored at -20°C for up to several weeks without 
loss of activity; a precipitate that formed occasionally upon thawing was removed by centrifuga- 
tion (900 g,  15 rain) and discarded before assay. 
Conditioned medium from other cultured lymphoid cell populations was prepared in the same 
way. These included spleen cells obtained after filtration through a column of nylon wool (Leuko- 
Pak; Fenwal Laboratories, Morton Grove, Ill.), thymus cells, and lymph node cells shaken free of 
fragmented thymus and axillary and mesenteric nodes, respectively. The amount of Con A present 
in the conditioned medium from stimulated lymphocytes (sLCM) was determined by stimulating 
the spleen cell preparation with ~H-Con A  (0.5 ~Ci/ml, 4 ~g/ml), and counting an aliquot of the 
sLCM in Aquasol-2 (New England Nuclear) at the time of collection. 
Culture of Peritoneal Macrophages.  Cells were obtained from NCS (The Rockefeller Univer- 
sity) mice (25-30 g) by washing the peritoneal cavity with 4  ml cold phosphate-buffered saline 
(PBS):  "normal" resident peritoneal  macrophages  were  cultured  from mice obtained from the 
specific pathogen-free colony immediately before sacrifice; "endotoxin" and "thioglycollate" mac- 
rophages were cultured from mice that had been injected 4 days previously with 30 ~g endotoxin 
(Salmonella  minnesota lipopolysaccharide  mR  595($418))  in  1  ml  PBS  or  with  1  ml  Brewer's 
thioglycollate medium, respectively. 
Fibrinolysis by Normal Macrophages.  Peritoneal cells (1  ×  106), frDm uninjected mice were 
plated onto IzsI-fibrin-coated wells of Linbro Disposo Trays (FB16-24TC; Linbro Chemical Co., New 
Haven,  Conn.) prepared as previously described (2), in Dulbecco's medium containing 0-50% of 
LCM in the presence of 5% of HI FBS and 100 pg/ml soybean trypsin inhibitor (STI). After 20 h of 
incubation, 2.5 x  108 latex particles [1.01  ~tm diameter, prepared as described elsewhere (2)] were 
added to some of the cultures; 1 h later all of the cultures were washed twice with 0.024 M Tris (pH 
7.4),  0.1  M  NaC1,  0.05  M  KC1,  and 0.0037 M  Na2HPO4  (TD),  and placed in Dulbecco's medium 
supplemented  with  8  pg/ml  human  plasminogen.  Aliquots  of the  supernatant  medium  were 
removed 3 h  and 6 h  later,  and assayed for solubilized radioactivity in a  Packard  Autogamma 
Scintillation Spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.). 
Fibrinolysis  by Endotoxin Macrophages.  Peritoneal  cells  (1  ×  l0  g)  from  endotoxin-injected 
mice  were  plated  onto  126I-fibrin-coated wells  of Linbro  Disposo  Trays  in  Dulbecco's  medium 
supplemented with 5% of HI FBS and 100 ~g/ml STI. After 20 h  of incubation the cultures were 
washed twice with TD  and placed in  Dulbecco's medium  containing 0-30% LCM,  and supple- 
mented with 5% of acid-treated HI FBS (1). Aliquots of medium were removed 6, 12, and 24 h later 
and assayed for solubilized radioactivity. 
Detection of  Plasminogen Activator Production by Single Cells.  Peritoneal cells (1  ×  104) were 
plated in Falcon 60-ram tissue culture Petri dishes (no. 3002), in Dulbecco's medium supplemented 
with  10%  of HI  FBS.  The  cultures  were  washed  after  6  h,  and placed  in Dulbecco's medium 
containing 0-30% LCM in the presence of 10% of HI FBS. The plates were washed 20 h later with 
TD, overlaid with a casein-agar mixture, incubated for 9 h, fxed, and stained; a full description of 
the  procedure  has  been  given  elsewhere. 1 The  overlay  mixture  was  prepared  either  with  or 
without human plasminogen (40 ~g/ml), and did not contain any LCM. 
Secretion of Plasminogen Activator by Thioglycollate Macrophages.  Peritoneal cells (5  ×  10  ~) 
from thioglycollate medium-injected mice were plated onto wells of Linbro Disposo Trays, in 1 ml 
Dulbecco's medium supplemented with 5% of HI FBS. The cultures were washed 20 h  later with JEAN-DOMINIQUE  VASSALLI  AND  E.  REICH  431 
TD, and placed in Dulbecco's medium containing 0-100% of LCM. After a further incubation of 24 
h  the  medium  was  collected  and  stored  at  -20°C  until assayed  for plasminogen  activator as 
previously described (2); the cells were washed three times with PBS and dissolved in 1 N  NaOH 
for determination of cell protein by the method of Lowry  et  al.  (6).  One  unit of plasminogen 
activator was defined as the amount that stimulated the release of 10% of the initial radioactivity 
in 4 h  (1). 
Results 
Induction of Plasminogen Activator  Production  in Cultures  of Normal Mac- 
rophages.  To test for a  possible effect of lymphocyte products,  macrophages 
obtained from untreated  mice were first cultured  for 20 h  in the presence of 
LCM, and then assayed for plasminogen-dependent fibrinolytic activity. As seen 
in Fig.  1,  sLCM greatly enhanced  fibrinolysis by macrophages;  the increased 
rate of fibrinolysis was a function of the concentration of sLCM and, after 6 h of 
assay, stimulation by as little as 0.3% of sLCM was detectable. In contrast,  no 
enhancement  of fibrinolysis was obtained in  macrophage  cultures  exposed to 
conditioned  medium  from  nonstimulated  lymphocytes  (NsLCM).  All  of the 
fibrinolytic activity induced by sLCM was plasminogen  dependent  and hence 
was attributable to macrophage plasminogen  activators. 3 
Two extrinsic factors that affect macrophage plasminogen activator synthesis 
are corticosteroids and phagocytizable particulates.  Low concentrations of anti- 
inflammatory  steroids,  which  are known to inhibit  enzyme production under 
other conditions (2) also blocked the effects of sLCM; addition of dexamethasone 
(10 -7 M) reduced the macrophage response to sLCM (30%) by more than  85% 
when the drug was present both during the preincubation period and the period 
of fibrinolysis assay. 
Exposure  of macrophage  cultures  to phagocytizable particles  may increase 
and/or prolong plasminogen  activator  secretion  (7).  When  cultures  of normal 
macrophages  were  exposed to  latex  particles  immediately  before assay,  the 
observed fibrinolytic activity was slightly increased  (Fig.  1,  insert);  a  similar 
effect of latex was detected in cultures pretreated with sLCM, but latex did not 
alter the shape of the dose response curve to sLCM. 
To test for the possibility that a minor subpopulation of normal macrophages 
was responding  to  sLCM,  the  proportion  of plasminogen  activator-producing 
cells in stimulated cultures was determined by means of a  casein-agar overlay 
procedure  that  detects  proteolysis  by single  cells.  As  shown  in  Fig.  2,  the 
proportion of proteolytically active cells was a  function of the concentration  of 
LCM in the preincubation  medium.  A  majority of macrophages responded to 
high  concentrations  of sLCM  and  all  of the  proteolytic  activity  was  due  to 
plasminogen  activators,  since  no  plaques  were  found  when  the  casein-agar 
overlay was deprived  of plasminogen.  In  this,  as in  other tests  (vide  supra) 
macrophages did not produce any detectable plasminogen activator in response 
to conditioned medium from lymphocyte cultures that had not been stimulated 
by mitogens. 
Apart from inducing plasminogen  activator production,  high concentrations 
3 It should be pointed out that LCM itself was not present during the fibrinolysis assay,  and 
therefore its continuous presence was not needed to maintain plasminogen activator production. 
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FIG.  1.  Fibrinolysis by normal  macrophages  plated  on  l~I-fibrin  and preincubat~  in 
presence of LCM. Normal macrophages  were preincubated either in the absence (0) or in 
the presence of various concentrations of sLCM ([~) or NsLCM (A), washed, and tested for 
fibrinolytic activity. For additional details see the Materials and Methods. Insert: Fibrino- 
lysis by normal macrophages plated on  ~25I-fibrin and preincubated  in presence of LCM; 
effect ofphagocytosis. Same experiment as in Fig. 1. At the end of the preincubation period 
the  cells were  exposed  to  latex  particles  (closed  symbols)  before being tested  for their 
fibrinolytic activity; 3 h  assay;  (open symbols),  no latex.  ([]-[],  m-.),  sLCM;  (A_ Lk, 
&-&), NsLCM; (O, O), no LCM. 
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FIG.  2.  Proportion of normal macrophages secreting plasminogen activator after preincu- 
bation in preSence of sLCM. All cells surrounded by a clear and concentric zone of lysis in 
the casein-agar overlay were scored as positive, irrespective of the size of the lysis zone. 
(10-30%) ofsLCM also stimulated morphological changes in normal macrophage 
cultures: sLCM-treated macrophages were square or round in outline, and they 
spread over a  larger surface than the untreated, star-shaped controls. In con- JEAN-DOMINIQUE  VASSALLI  AND  E.  REICH  433 
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FIG.  3.  Fibrinolysis by endotoxin macrophages plated on '~sI-fibrin and cultured in pres- 
ence of LCM. Cultures of endotexin macrophages were washed and assayed for fibrinolytic 
activity either in the absence (©) or in the presence of the indicated concentrations ofsLCM 
([3) or NsLCM  (A). 
trast, neither the plating efficiency of normal macrophages, nor their survival 
were affected by sLCM. 
Stimulation of Plasminogen Activator Secretion by Endotoxin- and by Thio- 
glycollate Medium-Primed Macrophages.  Macrophages harvested from endo- 
toxin-induced peritoneal exudates secrete little plasminogen activator, but they 
can be stimulated to much higher levels of enzyme production by exposure to 
phagocytizable particles (7), asbestos (8), Con A, or phorbol myristate acetate. ~ 
As seen in Fig. 3, plasminogen-dependent  fibrinolysis by these cells was rapidly 
and strongly enhanced upon exposure to sLCM; this effect persisted for at least 
24  h,  and its  magnitude was  a  function of the concentration of sLCM.  The 
proportion of plasminogen activator-secreting endotoxin macrophages, as de- 
tected by the casein-agar overlay technique, was also markedly increased after 
incubation with sLCM. 
Macrophages cultured from thioglycollate-induced peritoneal exudates se- 
crete high levels of plasminogen activator independent of any further stimula- 
tion in vitro (1); even so, enzyme production was increased as much as 10-fold in 
a dose-dependent manner when the cells were incubated in media enriched with 
sLCM.  The results of experiments using different preparations of LCM and of 
thioglycollate macrophages are presented in Fig.  4.  Although sLCM always 
caused a marked stimulation of plasminogen activator secretion, in contrast to 
the  lack  of effect of NsLCM,  the  extent  of this  stimulation  was  variable, 
reflecting perhaps in part a variation in the macrophage populations obtained 
after intraperitoneal injection of thioglycollate medium. 
The effect of sLCM is Not Due to Carry-Over of Con A.  Con A, when added 
directly to a purified population of cultured peritoneal macrophages, is a potent 
inducer and stimulant of plasminogen activator synthesis. ~  The possibility that 
the effects reported here might be due to the presence of Con A in the sLCM 
therefore required investigation. The actual amount of Con A present in sLCM 
(100%) was  determined by  using  3H-Con A,  and  found to  be  20  ng/ml,  a 
concentration 20-50  times lower than that required to obtain stimulation of 
plasminogen activator synthesis. ~  In addition, the effect of Con A and of sLCM 434  IN  VITRO  INDUCTION  OF  MACROPHAGE  PLASMINOGEN  ACTIVATOR 
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FIG. 4.  Plasminogen activator secretion by thioglycollate macrophages cultured in pres- 
ence of LCM. The data are pooled from two separate experiments. The amount of plasmino- 
gen activator secreted per milligram cell protein in the control, untreated cultures was 
defined as 1, and represented for experiment (a) (closed symbols)  1,150 U/mg cell protein, 
and for experiment (b) (open symbols) 860 U/mg cell protein. ([], M), sLCM; (A, A), NsLCM. 
TABLE  ][ 
The Effect of sLCM is Not Prevented by s-Methyl Mannoside 
Normal macrophages* 
Cells producing plasminogen acti- 
vator 
a-Methyl man- 
noside 
Thioglycollate macrophages$ 
Plasminogen activator secreted 
a-Methyl man- 
noside 
%  %  U/mg cell protein 
Control  3.5  8  623  1,048 
Con A (10/~g/ml)  30.2  9.8  8,865  2,580 
sLCM (30%)  57.8  56.5  7,563  11,189 
* Peritoneal cells from normal mice were plated and treated as described for Fig. 2.  a-Methyl 
mannoside  (0.1 M)  was  present  as  indicated during  the preincubation  period,  but  was not 
included in the casein-agar overlay mixture. 
$ Peritoneal cells from thioglycollate medium-injected mice were plated and treated as described 
for Fig. 4. a-Methyl mannoside (0.1 M) was present as indicated during the period of collection of 
macrophage-conditioned medium; when added to cell-free-conditioned medium, it did not affect 
the assay for plasminogen activator. 
on normal and on thioglycollate macrophages was compared (Table I):  both 
agents stimulated macrophage plasminogen activator production, but whereas 
the effect of Con A was blocked by addition of a-methyl mannoside, the effect of 
sLCM was unaffected by this sugar. These results demonstrated that the effect 
of sLCM was not due to any detectable carry-over of Con A, but rather to a 
molecule or molecules generated in cultures of Con A-stimulated spleen cells. 
Conditioned  Medium  from  Other  Lymphoid  Cell Populations.  To  test 
whether the stimulating factor formed by spleen cells might be a  product of 
lymphocytes, we have assayed for its presence in conditioned medium obtained 
both from cultured thymus and lymph node cells, and from the fraction of spleen JEAN-DOMINIQUE  VASSALLI  AND  E.  REICH  435 
cells that was not retained by a column of nylon wool. All three cell types gave 
qualitatively the same results as the routine unpurified spleen cells: in each case 
plasminogen activator  induction in  cultures  of normal  macrophages,  when 
tested with the casein-agar overlay technique as in Fig. 2, was observed only in 
presence of conditioned medium from Con A-stimulated lymphoid cultures. 
However, lacking any characterization of the active factor(s), we cannot assume 
that the results reflect the activity of a single inducing agent in all cases. 
Discussion 
Macrophages that have entered the peritoneal cavity in response to injected 
inflammatory agents produce relatively large amounts ofplasminogen activator 
(2).  There  are  persuasive grounds for  concluding that  the  secretion of this 
enzyme is  a  characteristic  property of migratory cells  and enables  them to 
transect the structural barriers encountered during migration (9-11).  In this 
view, plasminogen activator production would be one component in the cellular 
response to  stimuli that  provoke migration,  and  it  might be  expected that 
humoral factors capable  of recruiting macrophages to sites  of inflammation 
could be detected by the ability to induce enzyme synthesis. Our data show that 
cultured spleen cells exposed to the mitogenic lectin Con A yield products that 
(a) induce plasminogen activator synthesis by normal macrophages which do 
not spontaneously form this enzyme, and (b) stimulate enzyme synthesis over 
and above the appreciable amounts already produced by endotoxin and thiogly- 
collate macrophages. A  number of considerations suggest that this material 
may be of some physiological significance: (a) The stimulatory effect ofsLCM on 
plasminogen activator synthesis is detectable at high dilution, and the quantita- 
tive dose-response pattern of  macrophages resembles that commonly  observed in 
the responses of other cellular systems to hormones. (b)'At the level of individ- 
ual  cells macrophage response to  sLCM  is  not a  rare  event: essentially all 
macrophages are induced to synthesize plasminogen activator at the highest 
concentrations of sLCM. (c) Plasminogen activator production in this  I and other 
tissues, including ovarian cells (12), skin cells (H. Green and E. Reich, unpub- 
lished observations), and fibroblasts (13), can be induced by physiological levels 
of hormones or by correspondingly low concentrations of hormone-like sub- 
stances such as phorbol esters; and enzyme production by macrophages (2) as 
well as by certain cell lines (14) is suppressed by physiological concentrations of 
anti-inflammatory steroids. Hence inducibility of macrophage plasminogen ac- 
tivator by a  product of spleen cells is not surprising, and the active material 
could conceivably represent a humoral antagonist to the effect of glucocorticoids. 
Several details of the present work require brief comment. The spleen cells 
used for production of LCM are complex mixtures, and we have not, in fact, 
definitively identified lymphocytes as the source of LCM. Nevertheless, it seems 
safe tentatively to assume that the active factor is a lymphocyte product, since 
the replating procedure used in these experiments eliminates macrophages and 
other adherent cells, and washing incidentally also removes any macrophage 
plasminogen activator that might have accumulated during the preincubation 
period. Furthermore, the production of a similar inducing factor(s) by cultured 
thymic, lymph node, and partially purified nonadherent spleen cells suggests 436  IN  VITRO INDUCTION OF  MACROPHAGE PLASMINOGEN ACTIVATOR 
the lymphoid source of the active factor(s), although we cannot as yet assume 
that they are identical. 
We do not know whether or to what extent the active spleen cell factor in our 
experiments may be related to other activities of lymphocyte origin such as those 
responsible for modifying macrophage migration [migration inhibition factor 
(MIF)] (3), adherence to plastic (4), and electron-dense surface coats (15), one or 
more of  which might in fact reflect the action either ofplasminogen activator, or 
plasmin, or both.  It may be significant that the MIF-like activity present in 
conditioned medium produced by cultures of transformed mouse cells has been 
attributed to plasminogen activator (16). The definition of the relationships, if 
any, between these factors awaits their purification and characterization; since 
macrophage plasminogen activator synthesis is a useful assay for an inducing 
factor, the purification of the putative molecule is the subject of current efforts. 
Summary 
Macrophages obtained from the peritoneal cavity of untreated mice do not 
ordinarily synthesize plasminogen activator.  However,  induction of enzyme 
synthesis and secretion occurs when such macrophages are cultured in presence 
of  conditioned medium from Con A-stimulated spleen cells. Plasminogen activa- 
tor production by macrophages from endotoxin or thioglycollate medium-in- 
jected mice, which spontaneously secrete substantial amounts of the enzyme, is 
also markedly increased in presence of such conditioned medium. 
These results suggest that macrophage plasminogen activator production may 
be regulated in part by lymphocytes. They provide further evidence to  link 
macrophage plasminogen activator with cell migration and inflammation, and 
also support the view that in macrophages, as in certain other cell types, synthe- 
sis and secretion of this enzyme are under hormonal control. 
We thank Ms. A. Horiuchi, V. Iliescu, and M. Chun  for excellent  technical assistance. 
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